Skip to main content
SpringerLink
Log in

Inhalative Steroide bei COPD

Unter bestimmten Voraussetzungen sind sie entbehrlich

  • journal club
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Suissa S, Patenaude V, Lapi F et al. Inhaled corticosteroids in COPD and the risk of serious pneumonia. Thorax 2013;68:1029–36.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Wouters EFM, Postma DS, Fokkens B, et al. Withdrawal of fluticasone propio- nate from combined salmeterol/flutica- sone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial. Thorax 2005;60:480–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Literatur

  • Magnussen H, Disse B, Rodriguez-Roisin R et al. Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD. N Engl J Med 2014;371:1285–94.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rolshoverstraße 526, 51105, Köln, Deutschland

    Justus de Zeeuw (Facharzt für Innere Medizin Schwerpunkt Pneumologie, Schlafmedizin, Pneumologische Praxis)

Authors
  1. Justus de Zeeuw
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Justus de Zeeuw.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Zeeuw, J. Unter bestimmten Voraussetzungen sind sie entbehrlich. Pneumo News 7, 8–9 (2015). https://doi.org/10.1007/s15033-015-0053-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-015-0053-7

Search

Navigation